Katherine E. Brighty
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
- Pharmacology top 5%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Synthetic Organic Chemistry Methods 2
- Synthesis of heterocyclic compounds 2
- Asymmetric Synthesis and Catalysis 2
-
- Cancer therapeutics and mechanisms 4
- Chemical Synthesis and Analysis 2
- Co-authors
- Thomas D. Gootz (4 shared papers)Chin H. Chen (2 shared papers)Deepak Dalvie (1 shared paper)Joyce A. Sutcliffe (1 shared paper)S L Haskell (1 shared paper)Paul R. McGuirk (1 shared paper)Jack S. Remington (1 shared paper)Fausto G. Araujo (1 shared paper)
- Journals
- Tetrahedron Letters (3 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)The Journal of Organic Chemistry (2 papers)Diagnostic Microbiology and Infectious Disease (1 paper)Synlett (1 paper)
- Partner nations
- United States
In The Last Decade
Katherine E. Brighty
14 papers receiving 395 citations
Peers
Comparison fields: 5 of 68
- Molecular Medicine 127
- Pharmacology 197
- Organic Chemistry 141
- Clinical Biochemistry 23
- Applied Microbiology and Biotechnology 6
Countries citing papers authored by Katherine E. Brighty
This map shows the geographic impact of Katherine E. Brighty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Brighty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Brighty more than expected).
Fields of papers citing papers by Katherine E. Brighty
This network shows the impact of papers produced by Katherine E. Brighty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Brighty. The network helps show where Katherine E. Brighty may publish in the future.
Co-authors
The 25 scholars most cited alongside Katherine E. Brighty, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 147 | |
| 2 | 1997 | 108 | |
| 3 | 1994 | 37 | |
| 4 | 2000 | 27 | |
| 5 | 1996 | 23 | |
| 6 | 1999 | 22 | |
| 7 | 2011 | 14 | |
| 8 | 1993 | 12 | |
| 9 | 1981 | 7 | |
| 10 | 1980 | 7 | |
| 11 | 2010 | 4 | |
| 12 | 1988 | 4 | |
| 13 | 2010 | 3 | |
| 14 | 1996 | 2 |
About Katherine E. Brighty
Katherine E. Brighty is a scholar working on Organic Chemistry, Molecular Biology, Pharmacology, Molecular Medicine and Infectious Diseases, having authored 14 papers that have together received 417 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Antibiotic Resistance in Bacteria (4 papers), Synthetic Organic Chemistry Methods (2 papers), Synthesis of heterocyclic compounds (2 papers), Fluorine in Organic Chemistry (2 papers), Chemical Synthesis and Analysis (2 papers) and Asymmetric Synthesis and Catalysis (2 papers). The work is most often cited by research in Molecular Medicine (127 citations), Pharmacology (197 citations), Organic Chemistry (141 citations), Clinical Biochemistry (23 citations) and Applied Microbiology and Biotechnology (6 citations). Katherine E. Brighty has collaborated with scholars based in United States. Frequent co-authors include Thomas D. Gootz, Chin H. Chen, Deepak Dalvie, Joyce A. Sutcliffe, S L Haskell, Paul R. McGuirk, Jack S. Remington, Fausto G. Araujo, Anis A. Khan and Jonathan L. Doty. Their work appears in journals such as Tetrahedron Letters, Bioorganic & Medicinal Chemistry Letters, The Journal of Organic Chemistry, Diagnostic Microbiology and Infectious Disease and Synlett.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.